Breaking News, Financial News

Financial Report: Sanofi

Generic competition continues to hurt revenues

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi 1Q Revenues: €8.1 billion (-5%) 1Q Earnings: €1.6 billion (-36%) Comments: Diabetes sales grew 20% to €1.5 billion driven by Lantus. Consumer Healthcare sales were €811 million, up 3%. Vaccines sales increased 16% to €697 million driven by pediatric and flu vaccines. Genzyme sales grew 26% to €493 million, reflecting the recovery of Fabrazyme and the launch of Aubagio. Loss of exclusivity of Plavix, Avapro, and Eloxatin impacted earnings....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters